The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex
Open accessAbstract
We investigated oxidative stress in human postmortem frontal cortexfrom individuals characterized as mild cognitive impairment (n= 8), mild/moderate Alzheimer disease (n = 4), and late-stage Alzheimer disease (n = 9). Samples from subjects with no cognitive impairment (n = 10) that were age- and postmortem interval-matched with these cases were used as controls. The short postmortem intervalbrain samples were processed for postmitochondrial supernatant, nonsynaptic mitochondria, and synaptosome fractions. Samples were analyzed for several antioxidants (glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, glucose-6-phosphate dehydrogenase, superoxide dismutase, catalase) and the oxidative marker, thiobarbituric acid reactive substances. The tissue was also analyzed for possible changes in protein damage using neurochemical markers for protein carbonyls, 3-nitrotyrosine, 4-hydroxynonenal, andacrolein. All 3 neuropil fractions (postmitochondrial supernatant, mitochondrial, and synaptosomal) demonstrated significant disease-dependent increases in oxidative markers. The highest changes were observed in the synaptosomal fraction. Both mitochondrial and synaptosomal fractions had significant declines in antioxidants (glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase). Levels of oxidative markers significantly correlated with Mini-Mental Status Examination scores. Oxidative stress was more localized to the synapses, with levels increasing in a disease-dependent fashion. These correlations implicate an involvement of oxidative stress in Alzheimer disease-related synaptic loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, TNT formation is often associated with oxidative stress, another key feature of AD [120,121,122].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [121]
Experimental — accuracy not yet measuredIn the citing paper
“3-nitrotyrosine and protein carbonyls, these last produced mainly by the action of free radicals on the peptide chain or by oxidation of amino acids, are used as biomarkers of oxidative damage in the brain of AD and MCI [18,24,31,32,33].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
In the citing paper
“In response to OS in the brain, a number of protective mechanisms are up regulated to maintain the oxidative balance, in particular compensatory induction of antioxidant enzymes such as superoxide dismutase, glutathione reductase, catalase have been found in vulnerable neurons in AD [31].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
In the citing paper
“Reduction of antioxidants such as glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase are demonstrated post-mortem in the mitochondrial and synaptosomal fractions in the frontal cortex of MCI and AD patients [31].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Cited by
Sorted by citations
Items 501–600 of 623
ACSL4 in Alzheimer's disease: Pathogenetic mechanisms and potential therapeutic targets
Guo, Y. X., Jiang, Q., Gu, Z., Cao, H., Zuo, C., Huang, Y., Song, Y., Chen, X., & Wang, F. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101858 · Cited by 4
Lycium barbarum glycopeptide protects neurons from amyloid-beta toxicity
Chen, Z., Wang, X., Wang, S., Wu, Z., Wang, H., Chiu, K., Zheng, X., & So, K. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00501 · Cited by 2
Core Ferroptosis-Related Biomarkers and miRNA Regulatory Networks in Alzheimer’s Disease
Liu, W., Rao, X., & Yu, L. (2026) · Genes · doi:10.3390/genes17020224 · Cited by 2
Multitarget synthetic piperates against key drug targets of Alzheimer's and diabetes mellitus
Ahmad, A., Salar, U., Özil, M., Baltaş, N., Nasim, M., Ullah, A., Ul-Haq, Z., Khan, K. M., & Shaheen, F. (2026) · RSC Advances · doi:10.1039/d6ra00843g · Cited by 2
Yadav, B., Gangwar, P., Kumari, K., Yadav, A., Rao, R., Kumar, K., Verma, H., Dhiman, M., & Mantha, A. K. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1835778 · Cited by 2
Almeida, D. S., dos Santos, R. S., Anjos, M. J., Ferreira, S. T., de Souza, A. S., & Lopes, R. T. (2017) · X-Ray Spectrometry · doi:10.1002/xrs.2753 · Cited by 2
Inhibitors of Oxytosis/Ferroptosis: A New Class of Therapeutics for Alzheimer’s Disease
Maher, P. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-39171-2_22 · Cited by 2
Effect of oxidative stress on cognitive functions in children with obesity
Özer, S., Bütün, İ., & Bozkurt, H. (2024) · The European Research Journal · doi:10.18621/eurj.1476645 · Cited by 2
Targeting Mitochondria and Redox Dyshomeostasis in Brain Ageing: An Update
Cardoso, S., & Moreira, P. I. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-84965-8_8 · Cited by 2
Tackling Alzheimer’s Disease by Targeting Oxidative Stress and Mitochondria
Castellani, R. J., Correia, S. C., Moreira, P. I., & Perry, G. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00018-6 · Cited by 2
Taylor, C. E., Abdelhadi, S. O., & Dosoretz, C. G. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.07.010 · Cited by 2
RESVERATROL REVERSES BRAIN GLUTATHIONE SYSTEM INVOLVED NEURONAL LOSS AFTER IMMOBILIZATION STRESS
Kalpana, T. S. R., Ramya Sree, A., & Naveen Kumar, B. (2019) · International Journal of Anatomy and Research · doi:10.16965/ijar.2019.160 · Cited by 2
Hallam, R. D. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0531-21.2021 · Cited by 2
Panja, S., Siegel, D. M., Camandola, S., de Cabo, R., Ross, D., & Mallela, K. M. G. (2022) · Bioscience Reports · doi:10.1042/bsr20220643 · Cited by 2
ElNagar, A. S., Mohyeldin, M. M., Mostafa, N. M., Ibrahim, S. S. A., Batiha, G. E., Mahmoud, M. H., Hriţcu, L., & Eldahshan, O. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115382 · Cited by 2
Mandal, P. K., Sandal, K., Shukla, D., Tripathi, M., Singh, K., & Roy, S. (2020) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2020.571039 · Cited by 2
Detcheverry, F. E., Senthil, S., Motue, W. L. K., Hosein, C., Arnaoutelis, R., Araujo, D., Fetco, D., Assemlal, H.-E., Antel, S., Arnold, D. L., et al. (2024) · doi:10.1101/2024.09.24.24313962 · Cited by 9
Pal, M., Maurya, A., Shukla, R., Siddiqui, Z., Pathak, S. K., Srivastava, R., Shukla, V. K., Prasad, O., & Sinha, L. (2024) · Molecular Simulation · doi:10.1080/08927022.2024.2397463 · Cited by 1
Rodrigues, K. D. C., Oliveira, M. D. C., de Souza, I. C., Igansi, A. W., Lopes, A. V. B., Pacheco, C. O., Haas, S. E., Schumacher, R. F., & Luchese, C. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06967-9 · Cited by 2
Noman, M., Qadir, H., Ahmed, S., Rehman, N. U., Shah, F. A., Riaz, M., Ahmad, N., Ul‐Haq, Z., & Irshad, N. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00957 · Cited by 1
Tan, F. H. P., Najimudin, N., Azzam, G., Zainuddin, A., Shamsuddin, S., & Kasihmuddin, M. S. M. (2026) · Biogerontology · doi:10.1007/s10522-026-10388-2 · Cited by 1
Zainuddin, M.-S., Pamidi, N., Azman, A. S., Magalingam, K. B., & Bhuvanendran, S. (2026) · Redox Report · doi:10.1080/13510002.2026.2677396 · Cited by 1
From artery to memory: a comparative review of vascular cognitive impairment surgical models
Kane, M. M., Sneed, S. E., & Kaiser, E. E. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1861974 · Cited by 1
Galizzi, G. (2026) · Marine Drugs · doi:10.3390/md24070224 · Cited by 2
Mechanisms of neurotoxicity of fluoride or aluminum: implications for neurodegenerative disease risk
Wang, Z.-L., Baker, T. R., & Malin, A. J. (2026) · Current Research in Toxicology · doi:10.1016/j.crtox.2026.100313 · Cited by 1
Estresse Oxidativo como Fator Importante na Fisiopatologia da Doença de Alzheimer
Gemelli, T., de Andrade, R. B., Alexandre Luz Castro, Garcia, L. P., & Funcha, C. (2013) · Revista Brasileira Multidisciplinar · doi:10.25061/2527-2675/rebram/2013.v16i1.43 · Cited by 1
Early Aβ42 Exposure Causes Learning Impairment in Later Life
Cheng, K., Cheung, C. H. A., & Chiang, H. (2022) · Aging and Disease · doi:10.14336/ad.2021.1015 · Cited by 1
Kondeva-Burdina, M., Mitkov, J., Valkova, I., Peikova, L., Georgieva, M., & Zlatkov, A. (2022) · Molecules · doi:10.3390/molecules27165321 · Cited by 1
Mahajan, E., Raja, A., Sharma, A. R., Jain, A. K., Prabha, P. K., Prakash, A., & Medhi, B. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114720 · Cited by 1
Cytoprotective and Neuroinductive Effects of Thiol-Containing Simple Signaling Molecules
Dahlgren, K. J., Hemmerla, A. J., Moore, M. A., Calle, D., & Ulery, B. D. (2024) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-024-00370-0 · Cited by 1
Potential Role of Vitamin C in the Prevention of Alzheimer’s Disease
Murakami, K., Irie, K., & Shimizu, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407824-6.00061-6 · Cited by 1
POTENTIAL PROTECTIVE EFFECTS OF ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKADE IN ALZHEIMER RAT MODEL
Abood, A. (2019) · Ain Shams Medical Journal · doi:10.21608/asmj.2019.111155 · Cited by 1
Understanding the relationship between oxidative stress and cognition in the elderly
Perry, N., Martin, L., Rosenfeldt, F., Ou, R., Rowsell, R., & Stough, C. K. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820593-8.00006-9 · Cited by 1
Disorders of glutathione metabolism
Aoyama, K., Kinoshita, C., & Nakaki, T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00065-9 · Cited by 2
Nazifi, A. B., Abubakar, A., Magaji, M. G., Aliyu, M., & DANJUMA, N. M. (2022) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-022-00800-5 · Cited by 1
Ethno- Medicinal Properties of Glycyrrhiza Glabra L. (Licorice): A Mini Review
Saikia, Q., Hazarika, A., & Kalita, J. C. (2022) · International Journal of Life Science and Pharma Research · doi:10.22376/ijpbs/lpr.2022.12.3.p44-50 · Cited by 1
The Mechanisms of Human Glutathione Synthetase and Related Non-Enyzmatic Catalysis
Ingle, B. (2015) · doi:10.12794/metadc801927 · Cited by 1
tRNA-derived fragments elevated in Alzheimer’s disease promote Tau aggregationPreprint
Kobayashi, A., Han, C.-T., Nguyen, L., Tsay, K., Martins, M., Kharel, P., Zhang, Y., Barrasa, M. I., Williams, A. M., Kunii, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.17.725757 · Cited by 1
Sahni, J. K., Doggui, S., Dao, L. H., & Ramassamy, C. (2011) · Wiley eBooks · doi:10.1002/9780470960844.ch10
Antioxidants, diet, polyphenols and dementia
Sahni, J. K., Letenneur, L., Dao, L. H., & Ramassamy, C. (2011) · Elsevier eBooks · doi:10.1533/9780857092922.3.392
Gao, B. (2012) · HARVEST (University of Saskatchewan)
THE RELATIONSHIP BETWEEN DIETARY INTAKE AND GLUTATHIONE IN OLDER ADULTS
Evans, R. G. (2012) · KU ScholarWorks (The University of Kansas)
Fujihara, S. (2012) · Americanae (AECID Library)
da Silva, C. M. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-09062015-144939
double mutant knock-in mice model of Alzheimer disease as a function of age
Rukhsana Sultana, A., Abdul, H. M., Markesbery, W. R., Cai, J., Pierce, W. M. J., & Allan, D. (2011)
Disorders of Glutathione Metabolism
Aoyama, K., & Nakaki, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00061-9
Park, S., Jeong, W., Kim, K., Kang, D., Kim, S., & Kim, S. (2016) · International Journal of Current Research and Academic Review · doi:10.20546/ijcrar.2016.407.019
A characterization of deficits associated with loss of NCB5OR in the mouse brain
Stroh, M. A. (2016) · KU ScholarWorks (The University of Kansas)
Expression of Neural Glycans and Their Role in Disease
Kizuka, Y. (2017) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.1613.2e
The Role of Natural Compounds in the Treatment of Alzheimer's D isease
Hassanpour, S. H. (2018) · International Journal of Pharmacognosy & Chinese Medicine · doi:10.23880/ipcm-16000126
A DEFICIÊNCIA DE TIAMINA E NIACINA COMO FATOR DE RISCO PARA DE DOENÇAS NEUROLÓGICAS
de Oliveira, N. A. C., Magalhães, L. A., Matos, M. R. T., Aragão, G. F., & Bachur, T. P. R. (2019) · Infarma - Ciências Farmacêuticas · doi:10.14450/2318-9312.v31.e2.a2019.pp80-85
Petruski‐Ivleva, N. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/j7sy-9s93
Esfandi, R. (2017) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2017-12188
Tripathi, U. (2017) · OakTrust (Texas A&M University Libraries)
Gottlieb, M. G. V., Borges, C. A., Closs, V. E., Seibel, R., Schneider, R. H., Schwanke, C. H. A., & Gomes, I. (2021) · Current Aging Science · doi:10.2174/1874609814666210526115150
Leme, A. G. H. D. S. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.9.2021.tde-03082021-113014
Alzheimer’s Disease Results in Salivary Redox Imbalance Towards Oxidation ReactionsPreprint
Zalewska, A., Klimiuk, A., Zięba, S., Wnorowska, O., Rusak, M., Waszkiewicz, N., Szarmach, I. J., Dzierżanowski, K., & Maciejczyk, M. (2021) · Research Square · doi:10.21203/rs.3.rs-871834/v1
Abu a-Qasim al-Zahrawi's contribution to neurosurgery
Asharaf, A. B. M., & Shuriye, A. O. (2011) · IIUM Press eBooks
Presentación del Coloquio Internacional GRESCH: "¿Chile de país modelado a país modelo?”
le Chili, G. D. S. (2008)
Koçak, F. Ö. K. (2021) · The Turkish Journal of Geriatrics · doi:10.31086/tjgeri.2021.250
Yuan, Y., & Chen, F. (2019) · Springer eBooks · doi:10.1007/978-981-13-8118-8_3
Liao, P., Chang, C., Li, S.-W., Sung, P., Wang, R.-H., Wu, C., & Chen, Y.-C. (2022) · Research Square · doi:10.21203/rs.3.rs-1388089/v1
Coffee and Cognition: Extending Our Understanding beyond Caffeine
Bagchi, D., Moriyama, H., & Swaroop, A. (2016) · CRC Press eBooks · doi:10.1201/9781315371153-12
Expression of Neural Glycans and Their Role in Disease
Kizuka, Y. (2017) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.1613.2j
Computational Radical-Scavenging Activity Investigation of GalantaminePreprint
Karadjova, V., Saso, L., & Velkov, Z. A. (2022) · Research Square · doi:10.21203/rs.3.rs-2259044/v1
Circadian dysregulation and Alzheimer’s disease: A comprehensive review
Iacobelli, P. (2022) · Brain Science Advances · doi:10.26599/bsa.2022.9050021
Alkali, I. Y., Garba, M. M., & JamiluYa’u (2022) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2022.21.2.0407
Modified Investigation Tools and Techniques Useful in Alzheimer’s Disease Research
Deore, S. L., Baviskar, B. A., Kide, A. A., Khadabadi, S. S., & Shende, B. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_3
NRF2 in Neurological Disorders: A Molecular Beacon for Therapeutics
Verma, N. K. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004774 · Cited by 2
Nguyen, H. D., Vu, G. H., & Kim, W. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.101920
Zinka, R. B., Penumala, M., Shaik, J. B., Rao, K. Y., Mothukuru, S., Priya, V. K., Vadde, R., & Amooru, G. D. (2024) · Pharmacognosy Research · doi:10.5530/pres.16.2.32
Alzheimer’s Disease: Link to Biomolecular Mechanisms and Clinical Pathologies
Gezen‐Ak, D., & Dursun, E. (2024) · doi:10.69860/nobel.9786053359166.4
Disorders of glutathione metabolism
Aoyama, K., Kinoshita, C., & Nakaki, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19041-4.00031-5
Elyasi, L., Rosenholm, J. M., Jahanshahi, M., & Jesmi, F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04740-9
Culprits of Neurodegeneration in Alzheimer’s Diseases: Bench to Bedside Impression
Kumar, A., & Roy, A. (2025) · Central India Journal of Medical Research · doi:10.58999/cijmr.v4i01.224
Antioxidant Contents and Oxidative Stress Markers in Pediatric Familial Mediterranean Fever
Yasin, A., Demir, H., Üstyol, L., Akgeyik, Ş., Akgeyik, R., & Demir, C. (2025) · Van Sağlık Bilimleri Dergisi · doi:10.52976/vansaglik.1535898
Ivanova, P., Kortenska, L., Angelova, V. T., & Tchekalarova, J. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146553
Franco, F. N., Cardoso, L. D. C., Silva, B. N. M., de Araújo, G. R., & Chaves, M. M. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102291
Nutraceutical Antioxidants and Their Therapeutic Potential in Neurodegeneration
Ross, E. K. (2012) · Digital Commons - DU (University of Denver)
Diogo, V. S., Ferreira, H. A., & Prata, D. P. (2022) · Figshare · doi:10.6084/m9.figshare.20430647
Ivanova, S. A., Obreshkova, D. P., Mladenov, B. S., Petrov, N., & Stoyanova, M. (2026) · Springer eBooks · doi:10.1007/978-981-95-3823-2_6
Exploring the Role of Generalized Health Biomarkers in Traumatic Brain Injury: A UK Biobank Study
Sharma, S., & Lyall, D. M. (2025) · Journal of Biology and Health Science · doi:10.56147/jbhs.2.5.74
Matanaq, H. R., Mohammadzadeh, A., Sheykhsaran, E., Abbasi, A., Jafari-Sales, A., Rasizadeh, R., & Baghi, H. B. (2026) · Future Virology · doi:10.1080/17460794.2026.2635310 · Cited by 1
Singh, L. K., Singh, S. P., & Sharma, P. (2026) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2026.2644503
Karmakar, A., Roycowdhury, P., Sengupta, P., & Mukhopadhyay, D. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.02.007
Riaz, M., Qadir, H., Noman, M., Ahmed, S., Shah, F. A., Malik, M. U., Bashir, K., Farooq, U., & Irshad, N. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04744-4
Pathophysiology and Molecular Mechanisms of Alzheimer’s Disease
Chandragiri, S. S., Mathur, M., & Mathur, N. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814953126010005
Mishra, T., Sharma, S., Joshi, S., Prajapati, S. K., & Tejaswi (2025) · Neurophysiology · doi:10.1007/s11062-026-10002-8
Lee, J., Hong, E., Na, C., Li, Y., Go, J., Kim, J.-E., Seo, H.-H., Suh, J., Kwak, J., Lee, Y., et al. (2026) · Small · doi:10.1002/smll.74013
Wan, X., Lu, W., Liu, S., Zhao, Y., Hu, J., Ding, X., Gu, P., Zou, Y., Jiang, B., & Yang, Y. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.341
Ono, R. M. D. S., Lima, J. E. B. D. F., de Lira, J. A. S. P., Sanches, F. C., Piassi, L. D. O., Coelho, L. B. V., Moreira, N. C. D. S., & Sakamoto‐Hojo, E. T. (2026) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2025-0233
Arriagada, J., Brito, M. I. L., Lobos, P., Paz, A. A., Herrera, E. A., Muñoz, P., & Paula-Lima, A. C. (2026) · Neurotoxicity Research · doi:10.1007/s12640-026-00819-w
Gromadzka, G., Kąkol, M., Klimkiewicz, M., & Bendykowska, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167507
Keap1/Nrf2 mediated ferroptosis in early-life lead exposure-induced cognitive dysfunction in mice
Zhao, F., Huang, L., Yang, B., Wei, R., Qiao, F., Qi, Z., Li, H., Li, Z., Fang, Y., Peng, D., et al. (2026) · NeuroToxicology · doi:10.1016/j.neuro.2026.103554
Metadata
- Authors
- Ansari, M. A., & Scheff, S. W.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Scheff, Stephen W.
- ORCID
- Ansari, Mubeen A.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02
- Volume
- 69
- Issue
- 2
- Pages
- 155-167
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- PMC
- PMC2826839
- OpenAlex
- W2031762170
- Cited by
- 605
- References
- 96
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 44 · 2023: 40 · 2022: 51 · 2021: 56 · 2020: 44 · 2019: 38 · 2018: 30 · 2017: 31 · 2016: 41 · 2015: 29 · 2014: 31 · 2013: 24 · 2012: 31
- FWCI
- 21.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG-028383, AG27219, P30AG028383, P01AG014449, R01AG043375, R01AG027219)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, Alzheimer's disease, frontal cortex, synaptosomes, mitochondria, antioxidants, glutathione, superoxide dismutase, lipid peroxidation, protein carbonyls, nitrotyrosine, 4-hydroxynonenal, acrolein, synaptic loss, disease progression, mild cognitive impairment, postmortem brain
- MeSH terms
- Aged, Aged, 80 and over, Aldehydes, Alzheimer Disease, Antioxidants, Female, Frontal Lobe, Humans, Male, Mental Status Schedule, Synapses, Tissue Distribution, Tyrosine, Biomarkers, Thiobarbituric Acid Reactive Substances, Oxidative Stress, Disease Progression, Protein Carbonylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review